Clinical Trials in Philadelphia

Showing 3441-3460 of 15,860 trials

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

NCT04694846

This trial studies how well an enhanced tobacco intervention protocol (ETIP) works compared to standard treatment in helping head and neck and lung cancer patients starting treatment to reduce cigarette use. ETIP is an evidence-based tobacco cessation program including specialized one-to-one and telehealth counseling, drug therapy, nicotine replacement therapy, and frequent patient follow up. ETIP may help reduce smoking and improve cessation in patients with head and neck squamous cell cancer or non-small cell lung cancer.

Lung Non-Small Cell CarcinomaHead and Neck Squamous Cell Carcinoma

Thomas Jefferson University19 participantsStarted Aug 2020

Philadelphia, Pennsylvania, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

NCT01734512

This is an open label study of everolimus in children with recurrent or progressive low-grade glioma.

Pediatric Recurrent Progressive Low-grade GliomasPediatric Progressive Low-grade Gliomas

University of California, San Francisco65 participantsStarted Dec 2012

Los Angeles, California, United States • Los Angeles, California, United States • Oakland, California, United States +15 more locations

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Find Trials by Condition in Philadelphia

Neurofeedback to Treat Depression

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

EpiCare@Home Validation Study for Focal Onset Seizures

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Migraine and CVD Risk in Women

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A

Phase 2b Study of ALTO-100 in MDD

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Cognitive Behavioural Therapy to Optimize Post-Operative Recovery Trial

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Hemorrhagic Myocardial Infarction Detection by Post-reperfusion Troponin Kinetics

Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Skin Reactions Related to Thoracic Implantable Chamber Dressings